{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:31:44Z","timestamp":1763037104723},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T00:00:00Z","timestamp":1498003200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00393-017-0331-3","type":"journal-article","created":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T09:02:11Z","timestamp":1498035731000},"page":"509-523","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Gro\u00dfgef\u00e4\u00dfvaskulitiden"],"prefix":"10.1007","volume":"76","author":[{"given":"P. M.","family":"Villiger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,21]]},"reference":[{"issue":"1","key":"331_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA et\u00a0al (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65(1):1\u201311","journal-title":"Arthritis Rheum"},{"issue":"8","key":"331_CR2","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","volume":"33","author":"GG Hunder","year":"1990","unstructured":"Hunder GG, Bloch DA, Michel BA et\u00a0al (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33(8):1122\u20131128","journal-title":"Arthritis Rheum"},{"key":"331_CR3","doi-asserted-by":"crossref","first-page":"A544","DOI":"10.1016\/j.autrev.2012.01.003","volume":"11","author":"AT Borchers","year":"2012","unstructured":"Borchers AT, Gershwin ME (2012) Giant cell arteritis: a\u00a0review of classification, pathophysiology, geoepidemiology and treatment. Autoimmun Rev 11:A544\u20135","journal-title":"Autoimmun Rev"},{"issue":"8","key":"331_CR4","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/art.1780330811","volume":"33","author":"WP Arend","year":"1990","unstructured":"Arend WP, Michel BA, Bloch DA et\u00a0al (1990) The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33(8):1129\u20131134","journal-title":"Arthritis Rheum"},{"issue":"2","key":"331_CR5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/1759720X13512256","volume":"6","author":"WA Schmidt","year":"2014","unstructured":"Schmidt WA (2014) Role of ultrasound in the understanding and management of vasculitis. Ther Adv Musculoskelet Dis 6(2):39\u201347M","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"4","key":"331_CR6","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.berh.2016.09.010","volume":"30","author":"F Muratore","year":"2016","unstructured":"Muratore F, Pipitone N, Salvarani C, Schmidt WA (2016) Imaging of vasculitis: state of the art. Best Pract Res Clin Rheumatol 30(4):688\u2013706","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"331_CR7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/rheumatology\/keh513","volume":"44","author":"J Narvaez","year":"2005","unstructured":"Narvaez J, Narvaez JA, Nolla JM et\u00a0al (2005) Giant cell arteritis and polymyalgia rheumatic: usefulness of vascular magnetic resonance imaging studies in the diagnosis of aortitis. J\u00a0Rheumatol 44:479\u2013483","journal-title":"J Rheumatol"},{"key":"331_CR8","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1136\/ard.2003.015651","volume":"63","author":"AK Scheef","year":"2004","unstructured":"Scheef AK, Meeler J, Vosshenrich R et al (2004) Diagnosis and follow-up of aortitis on the elderly. Ann Rheum Dis 63:1507\u20131510","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"331_CR9","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1148\/radiol.14140056","volume":"273","author":"T Klink","year":"2014","unstructured":"Klink T, Geiger J, Both M et al (2014) Giant cell arteritis: diagnostic accuracy of MR imaging of superficial cranial arteries in initial diagnosis-results from a\u00a0multicenter trial. Radiology 273(3):844\u2013852","journal-title":"Radiology"},{"key":"331_CR10","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1136\/annrheumdis-2013-204572","volume":"73","author":"S Prieto-Gonz\u00e1lez","year":"2014","unstructured":"Prieto-Gonz\u00e1lez S, Depetris M, Garc\u00eda-Mart\u00ednez A et al (2014) Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a\u00a0prospective, case\u2013control study. Ann Rheum Dis 73:1388\u20131392","journal-title":"Ann Rheum Dis"},{"key":"331_CR11","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1007\/s00393-015-1674-2","volume":"75","author":"YH Lee","year":"2016","unstructured":"Lee YH, Choi SJ, Ji JD, Song GG (2016) Diagnostic accuracy of 18F-FDG PET or PET\/CT for large vessel vasculitis \u2013 a meta-analysis. Z\u00a0Rheumatol 75:924\u2013931","journal-title":"Z Rheumatol"},{"key":"331_CR12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.semarthrit.2006.12.005","volume":"37","author":"J Narvaez","year":"2007","unstructured":"Narvaez J, Bernad B, Roig-Vilaseca D et al (2007) Influence of previous corticosteroid therapy on temporal artery biopsy yield in giant cell arteritis. Semin Arthritis Rheum 37:13\u201319","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"331_CR13","first-page":"2165","volume":"30","author":"MA Hamidou","year":"2003","unstructured":"Hamidou MA, Moreau A, Toquet C et\u00a0al (2003) Temporal arteritis associated with systemic necrotizing vasculitis. J\u00a0Rheumatol 30(10):2165\u20132169","journal-title":"J Rheumatol"},{"issue":"3","key":"331_CR14","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/ard.2008.088351","volume":"68","author":"C Mukhtyar","year":"2009","unstructured":"Mukhtyar C, Guillevin L, Cid MC et\u00a0al (2009) EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 68(3):318\u2013323","journal-title":"Ann Rheum Dis"},{"key":"331_CR15","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1002\/art.22163","volume":"54","author":"M Mazlumzadeh","year":"2006","unstructured":"Mazlumzadeh M, Hunder GG, Easley KA et al (2006) Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a\u00a0double-blind, placebo-controlled, randomized prospective clinical trial. Arthritis Rheum 54:3310\u20133318","journal-title":"Arthritis Rheum"},{"issue":"5","key":"331_CR16","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/art.10262","volume":"46","author":"GS Hoffman","year":"2002","unstructured":"Hoffman GS, Cid MC, Hellmann DB et al (2002) A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum 46(5):1309\u20131318","journal-title":"Arthritis Rheum"},{"issue":"5","key":"331_CR17","first-page":"495","volume":"19","author":"RF Spiera","year":"2001","unstructured":"Spiera RF, Mitnick HJ, Kupersmith M et al (2001) A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA). Clin Exp Rheumatol 19(5):495\u2013501","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"331_CR18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.7326\/0003-4819-134-2-200101160-00010","volume":"134","author":"JA Jover","year":"2001","unstructured":"Jover JA, Hern\u00e1ndez-Garc\u00eda C, Morado IC et al (2001) Combined treatment of giant-cell arteritis with methotrexate and prednisone. a\u00a0randomized, double-blind, placebo-controlled trial. Ann Intern Med 134(2):106\u2013114","journal-title":"Ann Intern Med"},{"key":"331_CR19","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1002\/art.22754","volume":"56","author":"AD Mahr","year":"2007","unstructured":"Mahr AD, Jover JA, Spiera RF et al (2007) Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis. Arthritis Rheum 56:2789\u20132797","journal-title":"Arthritis Rheum"},{"issue":"2","key":"331_CR20","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/ard.45.2.136","volume":"45","author":"M Silva De","year":"1986","unstructured":"De Silva M, Hazleman BL (1986) Azathioprine in giant cell arteritis\/polymyalgia rheumatica: a\u00a0double-blind study. Ann Rheum Dis 45(2):136\u2013138","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"331_CR21","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/03009740500474537","volume":"35","author":"C Schaufelberger","year":"2006","unstructured":"Schaufelberger C, M\u00f6llby H, Uddhammar A et al (2006) No additional steroid-sparing effect of cyclosporine A in giant cell arteritis. Scand J Rheumatol 35(4):327\u2013329","journal-title":"Scand J Rheumatol"},{"issue":"9","key":"331_CR22","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/0003-4819-146-9-200705010-00004","volume":"146","author":"GS Hoffman","year":"2007","unstructured":"Hoffman GS, Cid MC, Rendt-Zagar KE et al (2007) Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a\u00a0randomized trial. Ann Intern Med 146(9):621\u2013630","journal-title":"Ann Intern Med"},{"issue":"5","key":"331_CR23","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/ard.2007.082115","volume":"67","author":"VM Mart\u00ednez-Taboada","year":"2008","unstructured":"Mart\u00ednez-Taboada VM, Rodr\u00edguez-Valverde V, Carre\u00f1o L et al (2008) A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects. Ann Rheum Dis 67(5):625\u2013630","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"331_CR24","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/ard.2007.086330","volume":"67","author":"C Salvarani","year":"2008","unstructured":"Salvarani C, Pipitone N, Boiardi L, Hunder GG (2008) Do we need treatment with tumour necrosis factor blockers for giant cell arteritis? Ann Rheum Dis 67(5):577\u2013579","journal-title":"Ann Rheum Dis"},{"key":"331_CR25","first-page":"w13156","volume":"141","author":"M Seitz","year":"2011","unstructured":"Seitz M, Reichenbach S, Bonel HM et al (2011) Rapid induction of remission in large vessel vasculitis by IL-6 blockade. A case series. Swiss Med Wkly 141:w13156","journal-title":"Swiss Med Wkly"},{"key":"331_CR26","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(16)00560-2","volume":"387","author":"PM Villiger","year":"2016","unstructured":"Villiger PM, Adler S, Kuchen S et al (2016) Tocilizumab for induction and maintenance of remission in giant cell arteritis: a\u00a0phase 2, randomised, double-blind, placebo-controlled trial. Lancet 387:1921\u20131927","journal-title":"Lancet"},{"issue":"4","key":"331_CR27","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/art.40037","volume":"69","author":"CA Langford","year":"2017","unstructured":"Langford CA, Cuthbertson D, Ytterberg SR et al (2017) A randomized, double-blind trial of Abatacept (CTLA-4Ig) for the treatment of giant cell arteritis. Arthritis Rheumatol 69(4):846\u2013853","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"331_CR28","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1136\/annrheumdis-2016-209351","volume":"75","author":"R Conway","year":"2016","unstructured":"Conway R, O\u2019Neill L, O\u2019Flynn E et\u00a0al (2016) Ustekinumab for the treatment of refractory giant cell arteritis. Ann Rheum Dis 75(8):1578\u20131579","journal-title":"Ann Rheum Dis"},{"key":"331_CR29","doi-asserted-by":"crossref","first-page":"8139","DOI":"10.1161\/CIRCULATIONAHA.111.058032","volume":"125","author":"D Saadoun","year":"2012","unstructured":"Saadoun D, Lambert M, Mirault T et\u00a0al (2012) Retrospective analysis of surgery versus endovascular intervention in Takayasu arteritis: a\u00a0multicenter experience. Circulation 125:8139","journal-title":"Circulation"},{"key":"331_CR30","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.1053\/j.semvascsurg.2011.04.002","volume":"24","author":"MA Qureshi","year":"2011","unstructured":"Qureshi MA, Martin Z, Greenberg RK (2011) Endovascular management of patients with Takayasu arteritis: stents versus stent Grafts. Semin Vasc Surg 24:4452","journal-title":"Semin Vasc Surg"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-017-0331-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-017-0331-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-017-0331-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T02:11:53Z","timestamp":1502244713000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-017-0331-3"}},"subtitle":["Riesenzellarteriitis und Takayasu-Arteriitis"],"short-title":[],"issued":{"date-parts":[[2017,6,21]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["331"],"URL":"https:\/\/doi.org\/10.1007\/s00393-017-0331-3","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,21]]}}}